Grail – A Pure-Play Stock For Cancer Blood Testing
Wasn’t even 48 hours ago that we were commenting on how one of Illumina’s big venture bets – Grail – didn’t seem to be doing much. And here we are today, poring over their S-1 filing as the...
View ArticleBiodesix – A Lung Cancer Diagnostics Stock
One can’t help but wonder why the Americans are so worried about peanut allergies when 34 million of them use a product every day that slowly kills them. In the United States, cigarette smoking is...
View ArticleWhy is Illumina’s Stock Price Falling?
Fewer than half of Americans own a passport. Some say that’s because their own backyard is such a big one. The half of our audience that hails from there may not be aware of what’s happening with...
View ArticleWhat’s Up With Illumina’s Acquisition of GRAIL?
If you want to land a job at a top investment bank, there’s an expectation that you’ve read certain material. Even though prop trading desks have gone the way of the dodo, books like Liar’s Poker and...
View ArticleGuardant Health Stock: The Storm Before the Storm
Given today’s investor has such high expectations of growth it seems prudent to wait until after an earnings announcement before purchasing a stock. Likewise, checking in with a company right before...
View ArticleWhy We No Longer Like Personalis Stock
As our tech investing methodology evolves, new rules help us better avoid risks and pitfalls by choosing companies that have proven their potential. Meaningful revenue of $10 million per year or more...
View ArticleCareDx Stock is Pure Play on Organ Transplant Diagnostics
You know those pop TV shows that ask burning questions like, “Where are they now?” Usually, the episode will pick some child star who flamed out early, spending the better part of their youth burning...
View ArticleIs Freenome a Leading Cancer Blood-Testing Company?
The meltdown of the cryptocurrency exchange FTX is just the latest reminder that it can take time – and billions of dollars lost – to catch fraud, even when there are more red flags waving than in a...
View ArticleGuardant Stock Plummets on Study Results
You know your consumer product is scaling when Katie Couric gives it a shout out. It’s even better when the product relates to something Ms. Couric feels very strongly about – colon cancer. Her husband...
View ArticleExact Sciences Stock Expands into Liquid Biopsy Market
Did you know that as early as the 1930s scientists were using wastewater – specifically, human excreta – to track disease outbreaks like polio well before the Rona came to town? Here’s another...
View Article
More Pages to Explore .....